Login to Your Account



U.S. Patent Disclosures


Thursday, May 5, 2011
LPath Inc., of San Diego, received U.S. Patent No. 7,901,682 for methods of treatment in cancer, pathological angiogenesis and inflammation using an antibody or antibody fragment that binds sphingosine-1-phosphate.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription